Aigen Investment Management’s BioNTech BNTX Stock Holding History

Aigen Investment Management’s Portfolio BNTX Stock Details BNTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-20,988	Closed	-$2M	–	540
2025 Q4	$2M	Buy	+20,988	New	+$2.11M	0.46%	50
2024 Q1	–	Sell	-4,880	Closed	-$515K	–	686
2023 Q4	$515K	Buy	+4,880	New	+$492K	0.09%	326
2022 Q1	–	Sell	-18,839	Closed	-$5.09M	–	593
2021 Q4	$5.09M	Buy	+18,839	New	+$5.16M	0.31%	74
2021 Q3	–	Sell	-7,913	Closed	-$1.77M	–	481
2021 Q2	$1.77M	Buy	+7,913	New	+$1.49M	0.31%	88

Other funds holding BNTX

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Flossbach Von Storch Cologne, Germany $22.1B AUM 6.81% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Aigen Investment Management's BNTX Position: Q1 2026 in Review

Aigen Investment Management sold out of BioNTech (BNTX) in Q1 2026, closing a stake of 20,988 shares — an estimated $2M sold.

Aigen Investment Management first reported a position in BNTX in Q2 2021 and held it in 4 quarters. The position peaked at $5.09M in Q4 2021. 272 funds tracked by Wall St. Rank hold BNTX as of Q1 2026.

Aigen Investment Management reported no remaining BioNTech position as of Q1 2026 after selling out during the quarter.
Aigen Investment Management sold 20,988 BioNTech shares in Q1 2026, an estimated $2M.
Aigen Investment Management first reported a position in BioNTech in Q2 2021 and held it in 4 quarters.
Aigen Investment Management's BioNTech position peaked at $5.09M in Q4 2021.
272 funds tracked by Wall St. Rank held BioNTech as of Q1 2026.

Based on Aigen Investment Management's 13F filing for Q1 2026, filed 15 May 2026.